Subscribe now

Insight and Health

Do new Alzheimer's drugs signal the end of the condition?

Antibody treatments that target amyloid plaques in the brains of people with Alzheimer's have shown promise in trials, but questions about their side effects and practicality remain

By Clare Wilson

24 May 2023

Illustration of amyloid plaques in a brain affected by Alzheimer’s disease

NOBEASTSOFIERCE/SCIENCE PHOTO LIBRARY

Judging by some recent newspaper headlines, the prospects of an effective treatment for Alzheimer’s disease have never been better. In the past couple of years, positive trial results have been announced for three drugs that clear a protein called amyloid – which is thought to play a crucial role in this form of dementia – from the brain.

But not everyone is convinced. Sceptics point out that these treatments won’t have much impact on symptoms. They can also cause dangerous …

To continue reading, subscribe today with our introductory offers

View introductory offers

No commitment, cancel anytime*

Offer ends 14th June 2023.

*Cancel anytime within 14 days of payment to receive a refund on unserved issues.

Inclusive of applicable taxes (VAT)

or

Existing subscribers

Sign in to your account